168 results
Page 4 of 9
8-K
EX-10.1
viuqdemzptnrmrpdsl
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
S-3ASR
xq4o vxy5
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
rsi372gdl 3p97h
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-5.1
h1zfnruzi8vocsngbxz
10 Aug 20
Automatic shelf registration
5:01pm
424B5
wk778
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
bg6p64za68e2s36gm
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-5.1
nb6qenui u2erl9s3
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
tv8yam48l8bup
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
bag5oi 36ihs150a
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
ww4xd676hzqgsy7b
29 Apr 20
Other Events
8:06am
8-K
wsjgzi8xezuhjx pq
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
EX-10.1
cqmd7p 0o8w87rb
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am